TY - JOUR
T1 - The ontogenesis of β-adrenergic receptors and of adenylate cyclase in the developing rat brain
AU - Keshles, Ofra
AU - Levitzki, Alexander
PY - 1984/10/15
Y1 - 1984/10/15
N2 - The development of β-adrenergic receptors in the developing rat brain was followed for the whole brain, the cortex and the cerebellum. The probe used was 125I-cyanopindolol. Through the use of this probe, the kinetics of appearance of preceptors was found to be different from that reported using 125I-hydroxybenzylpindolol as a probe. Also, the number of 125I-cyanopindolol sites is different from the number of 125I-hydroxybenzylpindolol sites. These differences are attributed to the difference in pharmacological specificity of the two ligands. 125I-cyanopindolol binds exclusively to β-receptors, whereas 125I-hydroxybenzylpindolol binds to both β-receptors and serotonin receptors. The ontogenesis of GppNHp dependent adenylate cyclase and of Mn2+/forskolin dependent adenylate cyclase indicate that the rate of synthesis of the catalytic component is faster than that of the GTP stimulatory component.
AB - The development of β-adrenergic receptors in the developing rat brain was followed for the whole brain, the cortex and the cerebellum. The probe used was 125I-cyanopindolol. Through the use of this probe, the kinetics of appearance of preceptors was found to be different from that reported using 125I-hydroxybenzylpindolol as a probe. Also, the number of 125I-cyanopindolol sites is different from the number of 125I-hydroxybenzylpindolol sites. These differences are attributed to the difference in pharmacological specificity of the two ligands. 125I-cyanopindolol binds exclusively to β-receptors, whereas 125I-hydroxybenzylpindolol binds to both β-receptors and serotonin receptors. The ontogenesis of GppNHp dependent adenylate cyclase and of Mn2+/forskolin dependent adenylate cyclase indicate that the rate of synthesis of the catalytic component is faster than that of the GTP stimulatory component.
UR - https://www.scopus.com/pages/publications/0021144419
U2 - 10.1016/0006-2952(84)90082-0
DO - 10.1016/0006-2952(84)90082-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 6091672
AN - SCOPUS:0021144419
SN - 0006-2952
VL - 33
SP - 3231
EP - 3233
JO - Biochemical Pharmacology
JF - Biochemical Pharmacology
IS - 20
ER -